Funding and purchase data for lenalidomide and bortezomib

Date sent: 27 July 2020

OIA response

27 July 2020

Dear [name and contact details withheld]

REQUEST FOR INFORMATION

Thank you for your request dated 28 June 2020 under the Official Information Act 1982 (OIA) for information relating to lenalidomide and bortezomib. You asked for:

Units of lenalidomide funded for each strength and pack size by month for the period 1 January 2018 to current (both Section B and H).
Units of bortezomib funded for each strength and pack size by month for the period 1 January 2018 to current (both section B and H).

The information you have requested is included in the tables below.

Please note that data is not yet available for the last few months. Section B data is dispensing data and may not include wastage. Negative figures in Section H data indicate where DHB hospitals may have on-sold stock.

We trust that this information answers your queries. We are making our information more freely available, so we will now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.

Yours sincerely

Rachel Read
Manager, Policy and Government Services

Lenalidomide: number of capsules dispensed

Community data (Section B)

Year Month	Cap 10 mg	Cap 15 mg	Cap 25 mg	Cap 5 mg
2018-01	2146	882	2116
2018-02	1799	998	1881
2018-03	2667	955	2184
2018-04	2422	882	1935
2018-05	2702	810	2448
2018-06	2466	756	2269
2018-07	2632	998	2562
2018-08	2469	1133	2100
2018-09	2220	1072	1988
2018-10	2636	1239	2352
2018-11	2576	1093	2163
2018-12	2531	1461	2111
2019-01	2588	1425	1848
2019-02	2303	1160	1704
2019-03	2291	1179	1638
2019-04	2519	1041	1890
2019-05	2813	1350	2250
2019-06	2219	858	1817
2019-07	2802	1246	2232
2019-08	2800	1154	2052
2019-09	2450	1132	2194
2019-10	2935	1144	2191
2019-11	2691	979	2131
2019-12	3029	1363	2517
2020-01	2954	1272	1921
2020-02	2334	1293	1834
2020-03	3028	1733	2184
2020-04	3312	2052	1774	28
2020-05	3716	1939	1810	84

Lenalidomide Number of capsules purchased

Hospital data (Section H)

Year Month	Cap 10 mg	Cap 15 mg	Cap 25 mg
2018-01	145	-63	-105
2018-02	-189	42	-126
2018-03	4	210	-189
2018-04	188	-42	210
2018-05	52	21	-232
2018-06	-12	0	-179
2018-07	-75	63	147
2018-08	82	-84	-63
2018-09	197	-168	133
2018-10	-117	0	-21
2018-11	271	-147	273
2018-12	187	294	273
2019-01	-180	-84	-315
2019-02	94	136	441
2019-03	62	11	-273
2019-04	10	73	126
2019-05	40	-115	-231
2019-06	-74	-53	126
2019-07	261	74	-168
2019-08	-43	21	-168
2019-09	188	-158	63
2019-10	199	137	210
2019-11	462	42	147
2019-12	441	168	252
2020-01	588	126	63
2020-02	294	0	126
2020-03	756	168	378

Bortezomib

Community data (Section B)

	Number of mg dispensed	Number of vials dispensed
Year Month	Inj 1 mg for ECP	Inj 3.5 mg vial
2018-01	1484.5	116.46
2018-02	1415.2	117.87
2018-03	1618.85	141.03
2018-04	1456.5	140.94
2018-05	1804.54	170.47
2018-06	1601.1	162.54
2018-07	1811.6	138.21
2018-08	1693.65	115.09
2018-09	1555.55	79.84
2018-10	1670.7	90.56
2018-11	1650.6	91.46
2018-12	1679	87.51
2019-01	1425.05	102.05
2019-02	1506.5	87.22
2019-03	1677.35	117.86
2019-04	1703.05	127.13
2019-05	1762.84	162.75
2019-06	1343.75	156.52
2019-07	1673.3	210.6
2019-08	1549.4	204.41
2019-09	1570.25	165.32
2019-10	1802.6	189.81
2019-11	1577.01	152.27
2019-12	1960.9	162.24
2020-01	1529.5	178.24
2020-02	1472.05	161.62
2020-03	1653.95	250.44
2020-04	1470.75	247.66
2020-05	1055.15	175.58

Bortezomib: Number of vials purchased

Hospital data (Section H)

Year Month	Inj 3.5 mg vial
2018-01	-64.46
2018-02	-16.87
2018-03	84.97
2018-04	23.06
2018-05	-19.47
2018-06	-6.54
2018-07	43.79
2018-08	5.74
2018-09	-14.84
2018-10	45.44
2018-11	-30.46
2018-12	63.84
2019-01	6.09
2019-02	-24.36
2019-03	22.93
2019-04	-34.78
2019-05	34.39
2019-06	32.48
2019-07	31.75
2019-08	40.45
2019-09	2.89
2019-10	27.62
2019-11	-33.27
2019-12	126.18
2020-01	67.48
2020-02	1.81
2020-03	22.56